Your browser doesn't support javascript.
loading
Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy.
Mellai, Marta; Cattaneo, Monica; Storaci, Alessandra Maria; Annovazzi, Laura; Cassoni, Paola; Melcarne, Antonio; De Blasio, Pasquale; Schiffer, Davide; Biunno, Ida.
Afiliação
  • Mellai M; Neuro-Bio-Oncology Center/Policlinico di Monza Foundation, Vercelli 13100, Italy.
  • Cattaneo M; Institute for Genetic and Biomedical Research, National Research Council, Milan 20138, Italy.
  • Storaci AM; Institute for Genetic and Biomedical Research, National Research Council, Milan 20138, Italy.
  • Annovazzi L; Neuro-Bio-Oncology Center/Policlinico di Monza Foundation, Vercelli 13100, Italy.
  • Cassoni P; Department of Medical Sciences, University of Turin/Città della Salute e della Scienza, Turin 10126, Italy.
  • Melcarne A; Department of Neurosurgery, CTO Hospital/Città della Salute e della Scienza, Turin 10126, Italy.
  • De Blasio P; ISENET Stem Cell Bank, Milan 20138, Italy.
  • Schiffer D; Neuro-Bio-Oncology Center/Policlinico di Monza Foundation, Vercelli 13100, Italy.
  • Biunno I; Institute for Genetic and Biomedical Research, National Research Council, Milan 20138, Italy.
Oncotarget ; 9(66): 32731, 2018 08 24.
Article em En | MEDLINE | ID: mdl-30220979
ABSTRACT
[This corrects the article DOI 10.18632/oncotarget.3611.].
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália